Poïesis Therapeutics is a biotechnology start-up focused on sourcing and in-licensing innovative late stage therapeutics and diagnostics from human biomedical research and developing them to address unmet needs in the veterinary market for companion animals – horses, dogs and cats.
Our mission statement adheres to the “one health” concept, reflective of the inherent synergies between animal and human medicine.
Developing new medicines to address unmet needs in animal health.
Developing new veterinary diagnostics to identify disorders in dogs, cats and horses.
Corporate Social Responsibility
Poïesis contributes a percentage of its profits to chosen charities which are making a difference for humans and animals.
Baylor Researchers Receive Grant to Study Canine Cancer, Test New Therapies for Translation to Human Cancers
Researchers at Baylor College of Medicine have been awarded a $500,000 grant from the National Institutes of Health that will increase our understanding about the interactions between cancer and the immune system in dogs with naturally occurring tumors. The grant...read more
By Arlene Weintraub, FiercePharma, September 30, 2016. Animal health has long been considered a safe investment, because even during tough economic times, most pet owners don’t scrimp on spending when it comes to keeping their dogs and cats healthy. And the food side...read more
By Helaine Olen, Slate, September 27, 2016. Pets certainly know how to sink their teeth into a household budget. In 2015, my poodle’s long-lasting stomach virus set my family back by almost four figures. Later in the year we got an even heftier bill for a canine root...read more
Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal Allergan could pay up to 19 times the value of the liver-disease treatment maker
NOTE: Poïesis is thrilled to announce that Laurent Fischer, MD, CEO of Tobira Therapeutics and an Advisor to the company has just presided over the acquisition of Tobira by Allergan plc for $1.7 Billion! By Tess Stynes, The Wall Street Journal, September 20, 2016....read more
By Sarah Evers Conrad, The Horse, September 9, 2016. Studying diseases across species can benefit horses as well as people -- Similarities between veterinary medicine and human medicine abound, particularly when it comes to horses. Horses, after all, suffer from many...read more
By Arlene Weintraub, FiercePharma Animal Health, August 29, 2016. Shares of animal health companies are outperforming the stock market as a whole, thanks largely to strong performances from companies like diagnostics maker IDEXX Laboratories ($IDXX), veterinary...read more
By Cathy Yarbrough, Contributing Editor, Life Science Leader, July 1, 2016. The animal health industry is on a growth trajectory, powered by the popularity of pet ownership and a global population hungry for meat and dairy products. The many large and small...read more
By K9 Magazine, April 6, 2016. Almost any dog owner who has lost a beloved dog to cancer has probably faced the reality that we do not yet have the same plethora of advanced treatments available for our four-legged friends that we have for people. Yet, our dogs share...read more
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.